Clinical Trials Directory

Trials / Terminated

TerminatedNCT02864316

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Nivolumab is effective in the treatment of radiation-induced solid tumors.

Conditions

Interventions

TypeNameDescription
DRUGNivolumab

Timeline

Start date
2016-12-01
Primary completion
2018-08-01
Completion
2018-09-01
First posted
2016-08-12
Last updated
2019-08-28
Results posted
2019-08-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02864316. Inclusion in this directory is not an endorsement.

Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure (NCT02864316) · Clinical Trials Directory